Person

Robert A. Michael

CHAIRMAN OF THE BOARD AND CEO · Director, AbbVie

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$20.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

  • ABBV
    AbbVie
    DirectorCHAIRMAN OF THE BOARD AND CEO
    since Mar 2017

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 29, 2024ABBVSale21,560$176.44$3.8M
Feb 29, 2024ABBVSale47,319$176.46$8.3M
Mar 1, 2022ABBVSale11,932$147.41$1.8M
Mar 1, 2022ABBVSale26,937$148.49$4.0M
Mar 1, 2022ABBVSale4,236$149.06$631K
Feb 28, 2018ABBVSale4,294$119.43$513K
Feb 20, 2018ABBVSale400$120.29$48K
Feb 20, 2018ABBVSale592$120.33$71K
Sep 28, 2017ABBVSale6,699$88.00$590K
Mar 10, 2017ABBVSale5,132$65.29$335K

SEC reporting-owner ID (CIK) 1699914 · all filings on EDGAR

Robert A. Michael (ABBV) | USBoard